These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28679965)

  • 21. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
    Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR
    J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma.
    Mitra S; Mukherjee S; Mehta J; Bhattacharyya M; Chakraborty H
    Indian J Pathol Microbiol; 2016; 59(3):427-8. PubMed ID: 27510699
    [No Abstract]   [Full Text] [Related]  

  • 24. CD117 (KIT) is a useful marker in the diagnosis of plasmablastic plasma cell myeloma.
    Marks E; Shi Y; Wang Y
    Histopathology; 2017 Jul; 71(1):81-88. PubMed ID: 28226184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The karyotype in paraproteinemias].
    Riva G; Spengler GA; Siebner H
    Minerva Med; 1971 May; 62(41):2081-4. PubMed ID: 4996374
    [No Abstract]   [Full Text] [Related]  

  • 26. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.
    Mori H; Fukatsu M; Ohkawara H; Oka Y; Kataoka Y; Taito S; Ikezoe T
    Int J Hematol; 2021 Dec; 114(6):639-652. PubMed ID: 34462886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
    Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
    In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cell myeloma and related neoplasms.
    Lorsbach RB; Hsi ED; Dogan A; Fend F
    Am J Clin Pathol; 2011 Aug; 136(2):168-82. PubMed ID: 21757591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma.
    Marini C; Baldaia H; Trigo F; Castillo JJ
    Am J Hematol; 2016 Aug; 91(8):E324. PubMed ID: 27012155
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection of 3q27 chromosomal abnormality in diffuse large B cell lymphoma using FISH on cell microarray].
    Jiang HY; Li HL; Zhao T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):73-7. PubMed ID: 18247310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.
    Sher T; Miller KC; Lee K; Chanan-Khan A
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):328-30. PubMed ID: 19717386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathologic and molecular genetic study of anaplastic lymphoma kinase-positive large B-cell lymphoma].
    Huang RF; CHEN G; GONG LP; LU LL
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):169-72. PubMed ID: 21575387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases].
    Su XY; Xu X; Tang Y; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):542-6. PubMed ID: 20021966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV.
    Chang ST; Liao YL; Lu CL; Chuang SS; Li CY
    Am J Clin Pathol; 2007 Aug; 128(2):339-44. PubMed ID: 17638671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case of lymphadenopathy with lytic bone lesions.
    Kalantri SA; Nath UK; Banerjee D; Bhattacharyya M
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28320703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
    Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.
    Vermeulen R; Saberi Hosnijeh F; Bodinier B; Portengen L; Liquet B; Garrido-Manriquez J; Lokhorst H; Bergdahl IA; Kyrtopoulos SA; Johansson AS; Georgiadis P; Melin B; Palli D; Krogh V; Panico S; Sacerdote C; Tumino R; Vineis P; Castagné R; Chadeau-Hyam M; ; Botsivali M; Chatziioannou A; Valavanis I; Kleinjans JCS; de Kok TMCM; Keun HC; Athersuch TJ; Kelly R; Lenner P; Hallmans G; Stephanou EG; Myridakis A; Kogevinas M; Fazzo L; De Santis M; Comba P; Bendinelli B; Kiviranta H; Rantakokko P; Airaksinen R; Ruokojarvi P; Gilthorpe M; Fleming S; Fleming T; Tu YK; Lundh T; Chien KL; Chen WJ; Lee WC; Kate Hsiao C; Kuo PH; Hung H; Liao SF
    Int J Cancer; 2018 Sep; 143(6):1335-1347. PubMed ID: 29667176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual case of plasmablastic non-Hodgkin's lymphoma located in the liver. First case reported in an AIDS patient.
    Metta H; Corti M; Maranzana A; Schtirbu R; Narbaitz M; De Dios Soler M
    Ann Hepatol; 2009; 8(3):242-5. PubMed ID: 19841505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
    Kadam Amare PS; Jain H; Nikalje S; Sengar M; Menon H; Inamdar N; Subramanian PG; Gujral S; Shet T; Epari S; Nair R
    Indian J Med Res; 2016 Oct; 144(4):536-543. PubMed ID: 28256461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.